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Abstract
Background: Glutamate, a major excitatory amino acid neurotransmitter, causes apoptotic neuronal cell
death at high concentrations. Our previous studies have shown that depending on the neuronal cell type,
glutamate-induced apoptotic cell death was associated with regulation of genes such as Bcl-2, Bax, and/or
caspase-3 and mitochondrial cytochrome c. To further delineate the intracellular mechanisms, we have
investigated the role of calpain, an important calcium-dependent protease thought to be involved in
apoptosis along with mitochondrial apoptosis inducing factor (AIF) and caspase-3 in primary cortical cells
and a mouse hippocampal cell line HT22.
Results: Glutamate-induced apoptotic cell death in neuronal cells was associated with characteristic DNA
fragmentation, morphological changes, activation of calpain and caspase-3 as well as the upregulation and/
or translocation of AIF from mitochondria into cytosol and nuclei. Our results reveal that primary cortical
cells and HT22 cells display different patterns of regulation of these genes/proteins. In primary cortical
cells, glutamate induces activation of calpain, caspase-3 and translocation of AIF from mitochondria to
cytosol and nuclei. In contrast, in HT22 cells, only the activation of calpain and upregulation and
translocation of AIF occurred. In both cell types, these processes were inhibited/reversed by 17β-estradiol
and Δ8,17β-estradiol with the latter being more potent.
Conclusion: Depending upon the neuronal cell type, at least two mechanisms are involved in glutamate-
induced apoptosis: a caspase-3-dependent pathway and a caspase-independent pathway involving calpain
and AIF. Since HT22 cells lack caspase-3, glutamate-induced apoptosis is mediated via the caspase-
independent pathway in this cell line. Kinetics of this apoptotic pathway further indicate that calpain rather
than caspase-3, plays a critical role in the glutamate-induced apoptosis. Our studies further indicate that
glutamate- induced changes of these proteins can be inhibited by estrogens, with Δ8,17β-estradiol, a novel
equine estrogen being more potent than 17β-estradiol. To our knowledge, this is the first demonstration
that glutamate-induced apoptosis involves regulation of multiple apoptotic effectors that can be inhibited
by estrogens. Whether these observations can help in the development of novel therapeutic approaches
for the prevention of neurodegenerative diseases with estrogens and calpain inhibitors remains to be
investigated.
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Background
High concentrations (mM) of the excitatory neurotrans-
mitter glutamate can accumulate in the brain and are
thought to be involved in the etiology of a number of neu-
rodegenerative disorders including Alzheimer's disease
[1,2]. A number of invitro studies indicate that at high
concentrations, glutamate is a potent neurotoxin capable
of destroying neurons by apoptosis [3,4]. We and others
have previously reported that glutamate induces charac-
teristic oligonucleosomal DNA fragmentation (DNA lad-
der) and apoptotic cell death by up and down-regulation
of Bax and Bcl-2, in a stable mouse hippocampal neuronal
cell line HT22 which lacks caspase-3, the primary activator
of apoptotic DNA fragmentation [5]. In contrast, in pri-
mary cortical cells, glutamate-induced cell death involves
upregulation of caspase-3 and its activation via a caspase-
dependent pathway involving mitochondrial signaling
[6]. Glutamate-induced DNA fragmentation observed in
HT22 cells implies that regulatory factors other than cas-
pase-3 are involved in the apoptotic process in these cells.
Recent studies demonstrate that calpain, a calcium-
dependent protease, and apoptosis inducing factor (AIF)
can play an important role in apoptotic cell death via a
caspase-independent apoptotic pathway [7-11]. Gluta-
mate toxicity appears to involve a rapid Ca2+ influx into
neurons and these high levels of intracellular Ca2+ are
cytotoxic [12,13]. Ca2+ can activate several key enzymes,
including nitric oxide synthase (NOS) and proteases such
as calpains and can also result in mitochondrial dysfunc-
tion [12,14]. Furthermore, a reduction in mitochondrial
transmembrane potential has been reported to accom-
pany AIF release and early apoptosis [15,16]. AIF is a ubiq-
uitously expressed flavoprotein with significant
homology to bacterial oxidoreductases and has NADH
oxidase activity [17]. Following induction of apoptosis,
AIF translocates from the outer mitochondrial membrane
to the cytosol and the nucleus, resulting in the induction
of nuclear chromatin condensation and large molecular
weight DNA fragmentation in a caspase-independent
manner [18,19]. Proteases such as caspases, calpains and
granzyme B [20-22], have been reported to play a critical
role in mediating apoptosis, especially the key modulator
caspase-3. Similarly, calpains have been implicated in
apoptosis in response to hypoxia and irradiation exposure
in neuronal and non-neuronal cells [23]. Calpain is a cal-
cium-dependent papain-like neutral cysteine protease,
which is widely distributed in neurons [23,24]. A number
of subcellular targets have been identified as substrates for
calpain cleavage, including spectrin, microtubules-associ-
ated protein (MAP), tau and neurofilaments, however, the
precise physiological role of calpain remains obscure [24].
Activation of calpain is triggered by an elevation of cyto-
plasmic free Ca2+ concentration which results in the cleav-
age of various proteins and culminates in cell death [25].
Activation of calpain is an early event in the onset of apop-
tosis in thymocytes therefore inhibitors of calpain can
reduce this process of cell death [26,27]. Calpain is also
implicated in neuronal cell death associated with cerebral
ischemia and other neuronal insults [28,29].
A number of studies have demonstrated that estrogens are
potent antioxidants that can inhibit some of the neuro-
toxic effects of oxidative stress [4,30,31]. We and others
have reported that estrogens can increase cell survival and
attenuate  invitrocell death induced by potential Alzhe-
imer's disease-related insults, such as exposure to oxidized
LDL and glutamate in a hippocampal cell line and pri-
mary cortical neurons [32-34]. The mechanism underly-
ing neuroprotection by estrogens against glutamate
oxidized neurotoxicity is not fully understood. Recently
we have reported that neuroprotection of estrogens
against glutamate cytotoxicity is associated with modula-
tion of the expression of Bcl-2 family of genes and cas-
pase-3 proteins, inhibition of cytochrome c release from
mitochondria into the cytosol and prevention of DNA
fragmentation [5,6]. In the present study, we selected two
cell types, primary cortical cells and hippocampal cell line
HT22, to investigate the roles of calpain, apoptosis induc-
ing factor (AIF) and caspase-3 in glutamate-induced apop-
tosis and its prevention by estrogens. The estrogens
chosen for this study were 17β-estradiol (17β-E2) and Δ8,
17β-estradiol (Δ8, 17β-E2), the latter being the more
potent antioxidant [35,36].
Results
Expression of ERα and ERβ mRNA in rat cortical cells
It has been reported that the HT22 cell line lacks estrogen
receptors [4]. In order to ascertain expression and relative
distribution of estrogen receptors ERα or ERβ in rat corti-
cal cells, we performed RT-PCR and Western blot analysis
(Figure 1). The results revealed that freshly isolated neuro-
nal cortical cells or cells after 7–8 days in culture expressed
both ERα and ERβ with the expression of ERβ being
higher than that of ERα. Both subtypes of ER mRNAs and
the corresponding proteins were found in the adult rat
uterus (positive control), with ERα levels higher than
those of ERβ. This is in keeping with a previous report
[41].
Anti-apoptotic effects of protease inhibitors of calpain and 
caspase-3 in mouse hippocampal cell line (HT22) and 
primary cortical cells
We have previously reported that glutamate treatment
induces apoptotic cell death in HT22 cells and primary
cortical cells in a time and dose-dependent manner [5,6].
We had shown that the commitment point to this death
was ~6 hours after initiation of 1 mM glutamate exposure
in primary cortical cells and for ~8 hour exposure with 7–
8 mM glutamate in HT22 cells. Based on these prelimi-BMC Neuroscience 2006, 7:49 http://www.biomedcentral.com/1471-2202/7/49
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nary data, all subsequent experiments were carried out
with a 6 hour treatment with 1 mM glutamate in primary
cortical cells and 8 hours with 7–8 mM glutamate in HT22
cells.
Effects of calpain and caspase inhibitors on glutamate-
induced cell death
(a) In mouse hippocampal cell line
Treatment of HT22 cells with 8 mM glutamate was initi-
ated in the presence or absence of various concentrations
of calpain I inhibitor (ALLN) or PD150606 for up to 8
hours. The results are depicted in Figures 2A and 2B.
Glutamate (8 mM) alone caused a significant increase
(50%) in cell death compared to control, while calpain
inhibitors, either ALLN or PD150606, reduced glutamate-
induced cell death in a dose-dependent manner. ALLN
(12.5–50 μM) reduced cell death by 50–70% (Figure 2A).
Similarly, 50 to 100 μM of PD150606 decreased cell death
by 70–100% (Figure 2B). However, when cells were
treated at a lower glutamate concentration (3–4 mM) for
a longer period (16 hours) however, cell death increased
by 40 to 50%, and this cell death was prevented by 12.5–
50 μM ALLN (data not shown). In the absence of gluta-
mate, neither inhibitor had an effect on cell viability. The
effect of calpain inhibitors on glutamate-induced apop-
totic cell death was also associated with characteristic
morphological changes (Figure 3). After an 8 hour incuba-
tion with 8 mM glutamate, degenerated and dead cells
were clearly visible in the culture (Figure 3B); the cellular
extensions (dendrites) seen in untreated HT22 cells (Fig-
ure 3A) were retracted and the cells appeared rounded and
had detached. In the presence of calpain inhibitors, 25 μM
ALLN or 100 μM PD150606, most cells survived and had
the appearance of normal untreated cells (Figure 3C and
3D). Only a small number of dead cells were visible in the
presence of 25 μM ALLN (Figure 3C). In contrast, caspase
inhibitors, either the specific caspase-3 inhibitor z-DEVD
(Figure 3E) or a pancaspase inhibitor z-VAD (Figure 3F) at
a concentration of 100 μM, failed to inhibit cell death
induced by 8 mM glutamate. This cell death was further
confirmed by using LDH release assay (data not shown).
(b) In primary cultures of rat cortical neuronal cells
To determine the role of calpain and caspase-3 in primary
cortical cells, cells were treated with 1 mM glutamate in
the presence or absence of calpain inhibitor (12.5 μM
ALLN) or specific caspase-3 inhibitor (50 μM z-DEVD) for
6 hours (Figure 4). Glutamate treatment alone induced
one fold increase (50%) in LDH release or cell death com-
pared to control. Caspase-3 inhibitor z-DEVD signifi-
cantly inhibited glutamate-induced cell death by 60%.
Similarly, the presence of calpain inhibitor ALLN resulted
Expression of estrogen receptors (ERα and ERβ) mRNA and protein in rat neuronal cortical cells Figure 1
Expression of estrogen receptors (ERα and ERβ) mRNA and protein in rat neuronal cortical cells. Rat cortical 
cells were cultured for 7–8 days and total RNA and protein were extracted. RT-PCR and Western blot analysis were carried 
out as described under "Methods". Rat uterus was used as a positive control.
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in a 70% reduction in (1 mM) glutamate -induced cell
death. These data indicate that both caspase and calpain-
mediated apoptosis were involved in glutamate-induced
cell death in primary cortical cells. However, the addition
of a combination of two protease inhibitors did not result
in a greater decrease in LDH release or cell death, suggest-
ing that calpain and caspase inhibitors has no synergetic
effects on glutamate-induced cell death. Protection by
both inhibitors was also detectable by characteristic mor-
phological changes (Figure 5). Thus after a 6 hour incuba-
tion with 1 mM glutamate, degenerated and dead cells
were clearly visible in the culture (Figure 5B), the cellular
extensions (dendrites) seen in untreated cortical cells (Fig-
ure 5A) were retracted, and cells appeared rounded. In the
presence of calpain inhibitors (12.5 μM ALLN) or caspase-
3 specific inhibitor (50 μM z-DEVD), dendrites were
retained and cells had the appearance of untreated normal
cells (Figures 5C and 5D), however, some degenerated
and dead cells were also visible. Activation of caspase-3
was also detected with a highly specific active caspase-3
antibody raised against amino acids 163 to 175 (p18 sub-
unit) of murine caspase-3 (data not shown). No change in
caspase-3 activity was found in HT22 exposed to various
concentrations of glutamate for up to 8 hours, while acti-
vation of caspase-3 significantly increased in glutamate-
treated cells in primary cortical cells as observed previ-
ously by us [6].
Effects of calpain and caspase inhibitors on glutamate-
induced DNA fragmentation
To further investigate the effects of calpain and caspase-3
inhibitors on glutamate-induced programmed cell death
(apoptosis), their effects on glutamate-induced character-
istic DNA fragmentation were determined. HT22 cells
were harvested after 8 hours or 16 hours of glutamate (8
mM) exposure in the presence or absence of calpain
inhibitors or caspase inhibitors. Total DNA was extracted,
purified and subjected to agarose gel electrophoresis. The
results indicate that untreated cells did not display any
DNA fragmentation (Figures 6A and 6B, Lane 1). In con-
trast, (8 mM) glutamate treatment resulted in characteris-
tic DNA fragmentation or laddering (Figures 6A, Lane 2)
that was associated with an increase in cell death. Addi-
tion of optimal doses of calpain inhibitors, 100 μM
PD150606 or 25 μM ALLN, reduced or blocked gluta-
mate-induced DNA fragmentation, (Figure 6A, Lanes 3
and 5). In contrast, in the presence of caspase inhibitors,
(8 mM) glutamate-induced DNA fragmentation (Figure
6B, Lane 4) was not prevented by either the caspase-3 spe-
cific inhibitor, 100 μM z-DEVD (Figure 6B, Lane 5) or 100
μM z-VAD (Figure 6B, Lane 6) for up to 16 hours. In the
absence of glutamate, none of the inhibitors alone (Fig-
ures 6A and 6B) had any effect on DNA fragmentation.
Determination of caspase and calpain activation
Activation of calpain and caspase-3 after glutamate expo-
sure in the primary cortical cells and HT22 cells was
assessed by Western blot analysis by examining proteoly-
sis of α-fodrin (α-II-spectrin) utilizing an epitope-specific
antibody directed against calpain or caspase-3 cleavage
site of α-fodrin. Cleavage of α-fodrin leading to formation
of 150/145 kDa breakdown fragments is a well-recog-
nized marker for the calpain-generated protein break-
down product (BDP) and formation of 120 kDa fragment
for the caspase-3 specific (BDP). Antibodies raised against
this epitope of α-fodrin have been shown previously to be
specific for calpain-cleaved α-fodrin breakdown products
145 kDa or/and 150 KDa (145/150 kDa BDPs) and cas-
pase-produced  α-fodrin breakdown products 120 KDa
(120 KDa BDP) [21,42]. The presence of α-fodrin BDPs
Effect of various concentrations of calpain inhibitors, ALLN  and PD150606, on glutamate-induced cell death in HT22  cells Figure 2
Effect of various concentrations of calpain inhibitors, 
ALLN and PD150606, on glutamate-induced cell 
death in HT22 cells. HT22 cells were treated with 8 mM 
glutamate in the presence or absence of 1–50 μM ALLN (A) 
and 1–100 μM PD150606 (B). Cell death was assessed by 
measuring LDH release after 8 hrs of treatment *P < 0.05 
compared to control; †P < 0.05 compared to glutamate 
alone.
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Effect of calpain and caspase inhibitors on glutamate toxicity in HT22 cells as assessed by phase contrast microscopy (20×) Figure 3
Effect of calpain and caspase inhibitors on glutamate toxicity in HT22 cells as assessed by phase contrast 
microscopy (20×). HT22 cells were treated with 8 mM glutamate in the presence or absence of calpain inhibitors, 25 μM 
ALLN and 100 μM PD150606, and caspase inhibitors, 100 μM z-DEVD and 100 μM z-VAD, for 8 hrs. Normal cells are 
depicted by arrows and degenerated cells by arrowheads. A = untreated control cells; B = glutamate alone; C = glutamate + 
ALLN; D = glutamate + PD150606; E = glutamate + z-DEVD; F = glutamate + z-VAD.
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145/150 and BDP 120 would suggest that calpain and cas-
pase-3 are activated under apoptotic conditions [43].
In HT22 cells, untreated cells contained the 240 KDa
intact α-fodrin band and following treatment with gluta-
mate, the 240 KDa band was cleaved into 145 KDa BDP,
but not the α-fodrin 120 KDa BDP in this cell line. As
shown in Figure 7A, glutamate induced calpain activity in
a time-dependent manner. Thus, calpain activity began to
increase at 6 hours after 7–8 mM glutamate exposure,
which preceded glutamate-induced LDH release and
apoptotic cell death, and was robustly activated by 7–8
hours. After a 14–16 hour treatment, degradation of
native α-fodrin was observed and BDPs were less noticea-
ble. The addition of calpain inhibitors (100 μM
PD150606 or 25 μM ALLN) completely blocked or
reduced glutamate-induced formation of 145 kDa BDPs
(Figure 7B), which is consistent with the observation that
they protect against glutamate-induced DNA fragmenta-
tion. These data further demonstrate that calpain protease
is indeed activated and mediates glutamate-induced
apoptotic cell death via a caspase-independent pathway in
HT22 cells.
In contrast to HT22 cells, cleavage of α-fodrin (240 kDa)
protein into 145 kDa and 120 kDa BDPs was found in
untreated cells (7–8 days of culture) (Figure 8A and 8B).
Similarly, glutamate treatment resulted in an increase in
the activity of calpain and caspase-3 in a time-dependent
manner. Formation of 145 kDa BDPs by calpain began to
increase earlier (0.5 hour) than the caspase-mediated 120
kDa BDP (3 hours), with greater accumulation of both
breakdown products (145 kDa and 120 kDa) after 6 hours
(Figure 8A). To further investigate the α-fodrin break-
down patterns produced by calpain or caspase-3, the
effects of calpain and caspase inhibitors on glutamate-
induced cleavage of α-fodrin were investigated by immu-
noblotting. The presence of calpain inhibitor 25 μM ALLN
reduced the formation of BDPs 145 kDa in primary corti-
cal cells exposed to glutamate, but it had no effects on 120
kDa BDP120 (Figure 9). However, the addition of cas-
pase-3 specific inhibitor 50 μM z-DEVD completely inhib-
ited the formation of 120 kDa BDP, but had no effect on
the formation of 145 kDa BDPs (Figure 9).
We have previously reported that primary cortical cells in
culture for longer than 2 days display characteristic DNA
fragmentation. To further detect whether cellular mecha-
nisms mediating this apoptotic process involve activation
of these proteases, cleavage of α-fodrin was measured by
using Western blot analysis with cells from fresh tissue,
day 0, day 1, day 3, days 7 and 8 in culture (Figure 8B).
Calpain-mediated cleavage of α-fodrin protein into 145
KDa BDPs could be seen on day 0 of culture (dissociated
cells prior to culture) prior to the initiation of DNA frag-
mentation (2 days). The activation further increased up to
7 days. Caspase-3-dependent 120 KDa BDP was detecta-
ble only after 7 days of culture. These data indicate that
apoptosis occurs during the development of the neuronal
cells (increasing days in culture) and is also associated
with calpain and caspase-3 activation. The results further
indicate that activation of calpain precedes the presence of
apoptosis characterized by DNA laddering and caspase-3
activity and suggest that calpain protease may be the first
protease in mediating neuronal apoptosis.
Effect of estrogens on the activation of calpain and 
caspase-3
We have previously reported that estrogens, 17β-estradiol
(17β-E2) and Δ8,17β-estradiol (Δ8,17β-E2), protect against
glutamate-induced cell death in a dose-dependent man-
ner. HT22 cells were treated with 7 mM glutamate for 7–
8 hours in the presence or absence of 1 μM and 10 μM
17β-E2 or Δ8,17β-E2. Cell death was measured by LDH
release assay and the results are summarized in Figure
10A. Both 17β-E2  and  Δ8,17β-E2  inhibited glutamate-
induced cell death, with Δ8,17β-E2 being more potent.
Thus, in the presence of 17β-E2, only 10 μM 17β-E2 could
significantly reduce cell death compared to glutamate
alone (Figure 10A). However, the presence of Δ8,17β-E2, 1
μM or 10 μM, completely inhibited cell death and
returned the release of LDH to control levels. In contrast,
in primary cortical cells exposed to 1 mM glutamate for 6
Effect of calpain and caspase inhibitors on glutamate-induced  cell death in primary cortical cells Figure 4
Effect of calpain and caspase inhibitors on glutamate-
induced cell death in primary cortical cells. Primary 
cortical cells isolated from 18 day old fetal rat brains were 
cultured for 7–8 days and treated with 1 mM glutamate alone 
or in the presence of the optimal concentration of 12.5 μM 
calpain inhibitor ALLN and 50 μM z-DEVD caspase-3 inhibi-
tor. LDH release (% maximum) was measured after 6 hrs of 
treatment *P < 0.05 compared to control; †P < 0.05 com-
pared to glutamate alone.
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hrs, 1 μM or 10 μM 17β-E2 or Δ8,17β-E2 could completely
protect against cell death (Figure 10B). Following meas-
urement of LDH, inhibition by estrogens of glutamate-
induced cleavage of α-fodrin in both cell types was deter-
mined by Western blot analysis. In HT22 cells, the pres-
ence of 10 μM 17β-E2 and 1 μM  Δ8,17β-E2 in 7 mM
glutamate for 8 hours significantly decreased glutamate-
induced cleavage of α-fodrin into 145 KDa BDP by 21%
and 51%, respectively, compared to glutamate alone (Fig-
ure 11A). However, 10 μM Δ8,17β-E2 totally inhibited the
formation of 145 KDa BDP. Moreover, in primary cortical
cells exposed to glutamate (1 mM) in the presence of
estrogens (1 μM and 10 μM 17β-E2 or Δ8,17β-E2) for 6
hours, estrogens not only inhibited calpain-mediated for-
mation of 145 KDa BDP, but also reduced caspase-3-
mediated formation of 120 KDa BDP (Figure 11B). Thus,
1 μM 17β-E2 significantly reduced breakdown products of
145 and 120 KDa compared to glutamate alone. Simi-
larly, 10 μM 17β-E2 and 1 μM Δ8,17β-E2 could completely
prevent activation of calpain and caspase-3 proteases and
totally block cleavage of α-fodrin. These data indicate that
estrogens protect against glutamate-induced apoptotic
cell death by inhibiting both calpain and caspase-3 activ-
ity in neuronal cells, with Δ8,17β-E2 being more potent.
Effect of calpain and caspase inhibitors on glutamate-induced cell death in primary cortical cells as assessed by phase contrast  microscopy (20×) Figure 5
Effect of calpain and caspase inhibitors on glutamate-induced cell death in primary cortical cells as assessed by 
phase contrast microscopy (20×). Primary cortical cells were isolated and treated as described under Figure 4. Normal 
cells are depicted by arrows and degenerated cells by arrowheads. A = untreated control cells; B = glutamate lone; C = gluta-
mate + ALLN; D = glutamate + z-DEVD.
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Effects of glutamate and estrogens on protein levels of 
apoptosis inducing factor (AIF) in different cell fractions 
from two cell types
Following the determination of calpain and caspase-3
protease's involvement in apoptotic cell death, regulation
of mitochondrial apoptotic effector AIF in cells undergo-
ing apoptosis was determined in primary cortical cells and
HT22 cells. Protein levels in cytosol, mitochondria, nuclei
and whole cell lysates were detected by Western blot anal-
ysis. In cortical cells, treatment with glutamate (1 mM)
resulted in an increase in AIF protein levels in the cytosol
and nuclei in a time dependent-manner (Figure 12A).
Concomitant with these changes, the levels of AIF protein
decreased in the mitochondria and no changes were
found in whole cell lysates. The elevation of cytosolic and
nuclear AIF and its reduction in the mitochondria were
associated with an increase in cell death. These results
indicate that AIF protein is released or translocates from
mitochondria into cytosol and nuclei in primary cortical
cells undergoing apoptotic cell death following exposure
to glutamate. However, exposure of HT22 cells to gluta-
mate (7–8 mM) enhanced AIF protein levels in all subcel-
lular fractions of cells in a time-dependent manner that is
also associated with glutamate-induced cell death. As
shown in Figure 12B, AIF protein levels were increased not
only in the cytosol and nuclei but also in the mitochon-
dria and whole cell lysates. These data demonstrate that
glutamate can upregulate AIF protein levels in HT22 cells.
Effect of calpain and caspase inhibitors on glutamate-induced DNA fragmentation (DNA ladder) in HT22 cells Figure 6
Effect of calpain and caspase inhibitors on glutamate-induced DNA fragmentation (DNA ladder) in HT22 cells. 
HT22 cells were treated with 8 mM glutamate in the presence or absence of calpain inhibitors 25 μM ALLN and 100 μM 
PD150606, and caspase inhibitors 100 μM z-DEVD and 100 μM z-VAD. A: HT22 cells were treated with glutamate in the pres-
ence of calpain inhibitors for 8 hrs. Lane 1 = untreated control cells; Lane 2 = glutamate alone; Lane 3 = glutamate + 
PD150606; Lane 4 = PD150606 alone; Lane 5 = glutamate + ALLN; Lane 6 = ALLN alone. B: HT22 cells were treated with 
glutamate in the presence of caspase inhibitors for 16 hrs. Lane 1 = untreated control cells; Lane 2 = z-DEVD alone; Lane 3 = 
z-VAD alone; Lane 4 = glutamate alone; Lane 5 = glutamate + z-DEVD; Lane 6 = glutamate + z-VAD; M: 100 bp DNA marker. 
Gel electrophoresis was carried out as described under "Methods" and the gels were stained with ethidium bromide.
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Glutamate-induced the cleavage of α-fodrin in HT22 cells and inhibition by calpain inhibitors as detected by Western blot anal- ysis Figure 7
Glutamate-induced the cleavage of α-fodrin in HT22 cells and inhibition by calpain inhibitors as detected by 
Western blot analysis. A: HT22 cells were treated with 7–8 mM glutamate for the indicated times. Control sample showed 
intact α-fodrin protein (240 kDa). Accumulation of calpain-mediated 145 kDa BDP was detected after 6 hrs of glutamate treat-
ment, but was not detectable after 24 hrs of treatment. There is no evidence showing caspase-3-produced 120 kDa BDP. B: 
HT22 cells were treated with 7–8 mM glutamate in the presence of calpain inhibitors, 100 μM PD150606 and 25 μM ALLN, for 
8 hrs. Both calpain inhibitors could block or reduce calpain-mediated 145 kDa BDP. Treatment with calpain inhibitors alone 
had no effect on proteolysis of α-fodrin. Each experiment was repeated 3 times and a representative example of the Western 
blot is shown.
A
D-Fodrin
240 KDa
145 KDa
240 KDa
145 KDa
B
Glutamate (7-8 mM)
Calpain Inhibitors
PD150606              ALLN
Actin


 120 KDa
Control    6 hrs     7 hrs    8 hrs     14 hrs
D-Fodrin
Actin


120 KDa
Glutamate
(7-8 mM)
 +        +         +       
  100 PM1 0 0   PM 25 PM   25 PMBMC Neuroscience 2006, 7:49 http://www.biomedcentral.com/1471-2202/7/49
Page 10 of 22
(page number not for citation purposes)
Glutamate-induced the cleavage of α-fodrin in primary cortical cells Figure 8
Glutamate-induced the cleavage of α-fodrin in primary cortical cells. A: primary cortical cells isolated from 18 day 
old fetal rat brains were cultured for 7–8 days and then cells were treated with 1 mM glutamate for the indicated times. West-
ern blot analysis showed that calpain-mediated 145 kDa BDP and caspase-3-mediated 120 kDa BDP could be detected in 
untreated control cells. Accumulation of 145 kDa BDP was evident at 0.5 hr earlier than that of 120 kDa BDP, with greater 
accumulation of both breakdown products occurring at 6 hrs. B: primary cortical cells were cultured for the indicated days and 
the cleavage of α-fodrin was detected by Western blot. Tissue sample only contained the intact 240 kDa α-fodrin protein but 
no cleavage products. Cleavage of the 240 kDa α-fodrin protein into 145 kDa BDP began at day 0 of culture (dissociated cells 
prior to seeding on plates) and the 120 kDa BDP of α-fodrin was only found after 7 days of culture. Each experiment was 
repeated 3 times and a representative example of the Western blot is shown.
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Effect of calpain and caspase-3 inhibitors on glutamate-induced cleavage of α-fodrin in primary cortical cells Figure 9
Effect of calpain and caspase-3 inhibitors on glutamate-induced cleavage of α-fodrin in primary cortical cells. 
Primary cortical cells isolated from 18 day old fetal rat brains were cultured for 7–8 days, and then cells were treated with 1 
mM glutamate alone or in the presence of calpain inhibitor 12.5 μM ALLN and caspase-3 inhibitor 50 μM z-DEVD for 6 hrs. (I): 
representative Western blots showing calpain and caspase-3- mediated proteolysis of α-fodrin and inhibition by protease inhib-
itors. (II): semi-quantitative analysis of calpain and caspase-3-mediated proteolysis of α-fodrin. Accumulation of breakdown 
products was assessed by Western blot analysis as described under "Methods". Actin was used as a loading control. The bars 
depict densitometric analysis of Western blots from at least three experiments (± SEM) *P < 0.05 compared to control; †P < 
0.05 compared to glutamate alone.
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Whether translocation of AIF is involved in this process
requires further study. The presence of estrogens, 1 μM
and 10 μM 17β-E2or  Δ8,17β-E2, decreased glutamate-
induced upregulation of AIF in HT22 cells and reduced
glutamate-induced AIF release from mitochondria into
cytosol in primary cortical cells. In HT22 cells, 1 μM 17β-
E2 significantly decreased AIF protein levels in whole cell
lysates by 40% compared to glutamate alone. Further-
more, 10 μM 17β-E2 and 1 μM Δ8,17β-E2 could reverse
glutamate-induced levels of AIF to control values (Figure
13A). Similarly in primary cortical cells, 1 μM 17β-E2 and
Δ8,17β-E2 could significantly reduce the release of mito-
chondrial AIF in cytosol by 30% and 50%, respectively
compared to glutamate alone (Figure 13B).
Discussion
The objective of this study was to investigate the cellular
mechanisms involved in glutamate-induced apoptotic cell
death in neuronal cells. We used the mouse hippocampal
cell line HT22 and primary fetal rat cortical cells to dem-
onstrate that glutamate can induce neuronal apoptotic
cell death by apoptotic mechanisms and that the process
can be reversed or inhibited by equine estrogens such as
17β-E2 or Δ8,17β-E2. The results further indicate that gluta-
mate-induced apoptotic cell death involves the activation
of apoptotic proteases calpain and caspase-3 as well as
upregulation and/or translocation of apoptosis-inducing
factor (AIF) from mitochondria into cytosol and nuclei,
where it causes nuclear condensation and apoptosis by a
caspase-independent pathway [44,45]. Our results reveal
that in these two cell types, primary cortical cells and the
HT22 cell line, cells display different patterns in regulating
specific proteins involved in apoptosis. Thus, in primary
cortical cells, glutamate-induced apoptotic cell death is
associated with activation of calpain and caspase-3, which
is in agreement with studies using different stimuli such as
staurosporine [46], and release of apoptosis-inducing fac-
tor (AIF) from mitochondria into cytosol and nuclei.
However in the mouse hippocampal cell line HT22, gluta-
mate-induced apoptotic cell death involved calpain pro-
tease activity and upregulation of AIF protein, but not
caspase-3 activity. Taken together, our data demonstrate
that glutamate-induced apoptotic cell death in neuronal
cells could be mediated by the apoptotic proteases calpain
and caspase-3 as well as mitochondrial apoptosis effector
AIF via a caspase-dependent or caspase-independent
apoptotic pathway that depends on the cell type. In HT22
cells, caspase-3 protein was not detectable and glutamate-
induced cell death occurred without elevation of caspase-
3 activity (data not shown). Caspase inhibitors, either the
specific caspase-3 inhibitor DEVD or the pancaspase
inhibitor z-VAD, are not capable of protecting against
glutamate-induced cell death in HT22 cells, while they do
inhibit glutamate-induced cell death in primary cortical
cells. In addition, glutamate-induced DNA fragmentation
(ladder) can be reduced or blocked by calpain inhibitors
but not by caspase inhibitors in this cell line. These results
strongly indicate that glutamate-induced apoptotic cell
death in HT22 cells is executed through a caspase-inde-
pendent pathway as has been observed in platelets [7].
Caspase-3 is considered a key executioner in the apoptotic
cell death cascade and shares numerous substrates with
Ca2+-dependent protease calpain such as cytoskeletal pro-
tein α-fodrin in which they cleave different epitope sites
once activated [24]. Though they both are capable of exe-
cuting apoptotic cell death, they appear to play different
Effects of estrogens, 17β-estradiol and Δ8,17β-estradiol, on  glutamate-induced cell death in HT22 cells and primary corti- cal cells Figure 10
Effects of estrogens, 17β-estradiol and Δ8,17β-estra-
diol, on glutamate-induced cell death in HT22 cells 
and primary cortical cells. A: HT22 cells were treated 
with 7 mM glutamate in the presence or absence of 1 μM and 
10 μM 17β-estradiol or Δ8,17β-estradiol for 8 hrs. Cell death 
was measured by LDH release assay. B: primary cortical cells 
isolated from 18 day old fetal rat brains were cultured for 7–
8 days and were treated with 1 mM glutamate in the pres-
ence or absence of 1 μM and 10 μM 17β-estradiol or Δ8,17β-
estradiol. LDH release was measured after 6 hrs of treat-
ment. Data are the mean ± SEM values from at least three 
experiments *P < 0.05 compared to control; †P < 0.05 com-
pared to glutamate alone.
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roles in this process. Our results show that immunoblots
probed with an anti-α-fodrin monoclonal antibody could
detect intact α-fodrin (MWr = 240 KDa) and 145 KDa and
120 KDa BDPs [47]. Treatment with glutamate induced
accumulation of both 145 KDa and 120 KDa BDPs in pri-
mary cortical cells, which could be reduced with both cal-
pain inhibitor (ALLN) and caspase-3 inhibitor (z-DEVD-
fmk). Thus, calpain inhibition specifically protects against
glutamate-induced production of 145 BDP and caspase-3
inhibition inhibits production of 120 BDP. There were no
synergetic effects on glutamate-induced apoptotic cell
death when these protease inhibitors were combined.
These studies indicate that both calpain and caspase-3 are
indeed activated, and their activation occurs sequentially
and independently after cells undergo apoptosis, suggest-
ing they may execute cell death to some extent by distinct
mechanisms in primary cortical cells. There is no evidence
showing that they have overlapping roles in cell death as
described previously in neuronal or non-neuronal cells
[43]. Moreover, in HT22 cells, only calpain-mediated α-
fodrin 145 KDa BDP appeared after glutamate treatment,
but 120 KDa BDP generated specifically by caspase-3
Effect of estrogens, 17β-estradiol and Δ 8,17β-estradiol, on glutamate-induced cleavage of α-fodrin in HT22 cells and primary  cortical cells Figure 11
Effect of estrogens, 17β-estradiol and Δ 8,17β-estradiol, on glutamate-induced cleavage of α-fodrin in HT22 
cells and primary cortical cells. A: HT22 cells were treated with 7 mM glutamate in the presence or absence of 1 μM and 
10 μM 17β-estradiol or Δ8,17β-estradiol for 8 hrs. B: primary cortical cells isolated from 18 day old fetal rat brains were cul-
tured for 7–8 days and treated with 1 mM glutamate in the presence or absence of 1 μM and 10 μM 17β-estradiol or Δ8,17β-
estradiol for 6 hrs. A, B: (I): representative Western blots showing calpain and caspase-3-mediated proteolysis of α-fodrin and 
inhibition by estrogens. A, B: (II): semi-quantitative analysis of calpain and caspase-3-mediated proteolysis of α-fodrin. Accumu-
lation of breakdown products was assessed by Western blot analysis as described under Figure 9. Actin was used as a loading 
control. The bar depict densitometric analysis of Western blots from at least three experiments (± SEM) *P < 0.05 compared 
to control; †P < 0.05 compared to glutamate alone.
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[47,48] could not be detected. Furthermore, glutamate-
induced cleavage of α-fodrin to 145 BDPs could be
reduced or blocked by calpain inhibitors, further indicat-
ing that glutamate-induced apoptosis is mediated by a cal-
pain cascade via a caspase-independent pathway in HT22
cells. Additional evidence for calpain's involvement in
apoptotic cell death in central nervous system is sup-
ported by recent studies examining invivotraumatic brain
injury TBI [49] and ischemia in the rat heart [50], in which
calpain-mediated cleavage of α-fodrin and DNA fragmen-
tation have been detected following these insults.
Calpain is a calcium-dependent neutral protease with two
isoenzyme forms, μ-calpain and m-calpain, distinguished
by their invitrocalcium requirements. Calpain exists as a
proenzyme in an inactive form in cytosol where the nor-
mal range of Ca2+ concentration is 50–100 nM in resting
cells [25,51]. An elevation of cytoplasmic free Ca2+ con-
centration triggers calpain activation, which also depends
upon the amount of calcium and site of activation. μ-Cal-
pain is activated in the presence of low micromolar levels
of Ca2+, and m-calpain requires millimolar Ca2+ levels for
its activation. After calpain is activated, it cleaves many
cytoskeletal proteins and signaling molecules such as
fodrin, filamine, neurofilament protein tau and tubulin
[24,51]. Fodrin (α II spectrin) was found to be a specific
calpain substrate [52,53]. In our studies, a calpain-medi-
ated cleavage fragment of α-fodrin was observed in two
Effect of glutamate on LDH release and AIF protein levels in subcellular fractions in HT22 cells and primary cortical cells Figure 12
Effect of glutamate on LDH release and AIF protein levels in subcellular fractions in HT22 cells and primary 
cortical cells. A: primary cortical cells were isolated as described under Figure 11 and were treated with 1 mM glutamate at 
the indicated times. B: HT22 cells were treated with 7–8 mM glutamate at the indicated times. A, B: (I): cell death were meas-
ured by LDH release assay. Data are the mean ± SEM values from at least three experiments *P < 0.05 compared to control; 
A, B: (II): subcellular proteins were isolated from cytosol, nuclei, mitochondria and whole cells as described under "Methods", 
and then AIF protein levels were detected by Western blot analysis. Actin was used as a loading control.
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Effect of estrogens, 17β-estradiol and Δ8,17β-estradiol, on AIF protein levels during glutamate-induced cell death in HT22 cells  and primary cortical cells Figure 13
Effect of estrogens, 17β-estradiol and Δ8,17β-estradiol, on AIF protein levels during glutamate-induced cell 
death in HT22 cells and primary cortical cells. A: HT22 cells were cultured and were treated as described under Figure 
11. Cells were then harvested and total protein was extracted. AIF protein levels were determined by Western blot analysis. 
The bars depict densitometric analyses from at least three experiments (± SEM). *P < 0.05 compared to control; †P < 0.05 
compared to glutamate alone. B: cortical cells were isolated as described under Figure 11 and were treated with 1 mM gluta-
mate in the presence or absence of 1 μM 17β-estradiol or Δ8,17β-estradiol for 6 hrs. Cytosol protein was isolated and AIF 
protein levels were detected as described under "Methods". Actin was used as a loading control.
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cell types exposed to glutamate, as seen in the dystrophic
neuritis and senile plaques in Alzheimer's diseased brains
[54], suggesting that calpain could be a major apoptotic
protease involved in the pathogenesis of neurodegenera-
tive diseases.
It has been reported that calpain could be activated in
both necrotic and apoptotic conditions as observed in var-
ious neurological and neurodegenerative disorders, such
as cerebral ischemia and glutamate toxicity [55,56], while
caspase-3 is only activated in neuronal apoptosis [44,57-
59]. Nevertheless, in our model systems, glutamate-
induced cell death in HT22 cells was found to involve the
mechanism of apoptosis (programmed cell death) charac-
terized by the presence of DNA fragmentation (DNA lad-
der) and morphological cell changes, and this process
could be attenuated by calpain inhibitors and not caspase
inhibitors. Thus, in cortical cells, both 145 KDa and 120
KDa BDPs were formed in untreated cells and cells treated
with glutamate, which was also associated with DNA frag-
mentation (data not shown), and calpain-mediated 145
KDa BDP accumulated to a greater extent than 120 BDP.
Furthermore, activation of calpain precedes that of cas-
pase-3, glutamate-induced LDH release (cell death) and
DNA fragmentation in these cells. Taken together, our
results strongly suggest that calpain, rather than caspase-3,
plays a critical role in mediating apoptosis characterized
by oligonucleosomal DNA fragmentation (DNA ladder)
and is a key apoptotic executioner in neuronal apoptosis,
especially in HT22 cells. Whether calpain activity is asso-
ciated with necrosis needs to be investigated.
We have previously reported that glutamate induces cyto-
chrome c release from the mitochondria into the cyto-
plasm where it activates caspase-3 and causes apoptotic
cell death in primary cortical cells via a caspase-dependent
pathway [6]. In the present paper, we show that apoptosis
inducing factor (AIF), normally confined in the mito-
chondria, is also released into the cytosol and nuclei in
primary cortical cells undergoing apoptosis and upregula-
tion of AIF also occurs in HT22 cells after glutamate treat-
ment. In contrast to cytochrome c, AIF acts in a caspase-
independent fashion [19,60]. AIF is a ubiquitously
expressed flavoprotein with significant homology to bac-
terial oxidoreductases and has NADH oxidase activity
[17]. Under normal circumstances, transcription and
translation of nuclear AIF gene give rise to a precursor
molecule (67 KDa) that carries a putative mitochondrial
localization sequence in its NH2 terminus [60]. Upon
import into the mitochondrial intermembrane space, this
100 amino acid precursor is cleaved by a local peptidase
leading to generation of the mature AIF molecule (57
KDa). When apoptotic cell death is induced, AIF translo-
cates through the outer mitochondrial membrane to the
cytosol and nucleus, where it leads to nuclear chromatin
condensation and a large-scale DNA fragmentation (high
molecular weight DNA fragments) and apoptosis in a cas-
pase-independent manner [10,11]. Recent studies show
that microinjection of mature AIF and precursor AIF can
both induce chromatin condensation and cell death
[61,62]. It was further found that transfection enforced
overexpression of the wild type precursor AIF (precursor
AIF protein) also diminishes the permeability of the mito-
chondrial membrane (ΔΨμ), induces AIF release from the
mitochondria and causes apoptosis. Based on these stud-
ies, glutamate-induced overexpression of AIF in HT22
cells might also trigger AIF release or translocation from
the mitochondria into the cytosol and nuclei. This process
needs to be further elucidated. Taken together with previ-
ous studies, our data indicate that glutamate exerts its
toxic action through two parallel pathways: a caspase-
dependent pathway mediated by caspase-3, the final
apoptotic effector, and a caspase-3 independent apoptotic
pathway involving the upregulation of AIF and/or mito-
chondrial AIF release as well as calpain-modulated effects
(cell death).
We have previously reported that a number of equine
estrogens, which are components of the drug CEE used
extensively for management of vasomotor symptoms and
osteoporosis in postmenopausal women, are potent anti-
oxidants and protect neuronal cells against cell death
induced by oxidized LDL or glutamate [32,33,35,63-65].
Our current findings indicate that estrogens prevent gluta-
mate-induced cell death by reducing the upregulation
and/or translocation of AIF from the mitochondria into
the cytosol as well as by attenuating activity of calpain and
caspase-3 in primary cortical cells and HT22 cells, with Δ8,
17β-estradiol being more potent than 17β-estradiol.
Although neurotoxic effects of oxidized LDL and gluta-
mate can be inhibited differentially by various estrogens,
[32,33,35], the data presented in this paper, to our knowl-
edge, represents the first comprehensive analysis of the
involvement of multiple apoptotic proteins in glutamate-
induced apoptosis in different neuronal cells that can be
differentially inhibited by equine estrogens. Recent stud-
ies have shown that estrogen can decrease calpain activity
in rat C6 glial cells treated with H2O2 and in ischemic
muscle [66,67]. The regulation by estrogens on the trans-
location of apoptotic effectors from the mitochondria
into the cytosol such as cytochrome c and the activation
of caspase-3 has been discussed in previous reports in
which estrogens might directly modulate the mitochon-
drial Ca2+ content and mitochondrial trans-membrane
potential [6]. As the estrogen receptor has been shown to
be a substrate of calpain, estrogen-mediated reduction of
calpain activity may prevent degradation of the ERs, and
enable receptor-mediated events to proceed by genomic
mechanism [68]. Whereas in HT22 cells lacking estrogen
receptors, estrogen effects are most-likely mediated toBMC Neuroscience 2006, 7:49 http://www.biomedcentral.com/1471-2202/7/49
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some extent by non-genomic mechanism [4,69]. It may
also be related to an effect on voltage-gated Ca2+ channels
and reduced post-injury influx of Ca2+ [70]. It has been
reported that estrogen treatment can attenuate Ca2+ influx
in cultured neurons [71]. However, our earlier findings
indicate that estrogens protected primary cortical cells
against glutamate induced excitotoxicity by a mechanism
that appears to be independent of Ca2+ influx [13]. In this
study in primary cultures of cortical neurons, we investi-
gated the glutamate-induced excitotoxicity by exposing
the neurons to μM concentration of glutamate for only 20
minutes. The results from this study indicated that gluta-
mate-induced cell death occurs through NMDA receptors
and NOS-linked mechanism independent of Ca2+ influx
and this form of cell death was also prevented by estro-
gens. A recent study [72] has confirmed our latter observa-
tions in neuronal cells derived from fetal rat brains,
however, these investigators also used middle aged and
old rats neurons where there was a profound loss of cal-
cium homeostasis more so in the older age group. These
observations indicate that neurons from older rats are
more sensitive to glutamate toxicity, however, as in neu-
rons from fetal brains, estrogens were also able to protect
these older neurons. Whether the role of calpain, caspase-
3 and AIF is altered in cortical neurons derived from older
animals remains to be investigated.
Pre-treatment of these neurons with 17β-estradiol prior to
exposure to glutamate attenuate and delay the adverse
effects on intracellular Ca2+ homeostasis. Whether the role
of calpain, caspase-3 and AIF is altered in cortical neurons
derived from older rat brains remains to be investigated.
Our observations further suggest that the neuroprotective
effects of estrogens can involve both genomic and non-
genomic mechanisms that depend on the neuronal cell
type and the cytotoxin used to induce apoptosis.
Recently, Bano et al [73] reported that the Na+/Ca2+
exchanger (NCX) which under normal physiological con-
ditions, transports Na+ ions into the cell and Ca2+ out, is
destroyed by Ca2+-activated calpain under ischaemic con-
ditions. This proteolytic inactivation of NCX could allow
further accumulation of Ca2+ or delay its elimination, that
ultimately results in the destruction of the neurons.
Whether glutamate induced Ca2+ influx and the activation
of calpain observed in our neuronal cells also results in
the inactivation of NCX that can be prevented by estrogen
remains to be investigated.
Although our present data and those of a number of pre-
vious studies [20,21,23,24,26-29] indicate that calpains
play a critical role in mediating apoptotic cell death, oth-
ers indicate that in cerebellar granule cells and rat fetal
hippocampal neurons activation of NMDA receptors is
necessary for calpain-1 activation but no association
between calpain activation and glutamate-induced cell
death was observed [74-76]. Differences between these
observations could be due to several factors such as cell
type, primary cell cultures or stable cell line cultures, tis-
sue culture conditions, source of cells (fetal, middle age or
adult brains), age of cultures, purity of cultures concentra-
tion and duration (minutes to hours) of glutamate expo-
sure, nature of the neurotoxin used, and extent of Ca2+
influx [13,74-76]. Along with these, a number of addi-
tional differences have been indicated [76]. Further
detailed studies are needed to delineate the role of cal-
pains in glutamate-induced apoptotic neuronal cell death
in clearly defined model systems. It is also important to
recognize that at least two distinct pathways for gluta-
mate-induced cell death have been described: the excito-
toxic pathway and the oxidative pathway. The excitotoxic
pathway involves the overactivation of glutamate recep-
tors that leads to both rapid and slowly triggered cytotoxic
events. The rapid effects involve the activation of the
NMDA receptor and leads to a large Ca2+ influx that is
detrimental to cell viability. The oxidative pathway
involves the breakdown of the glutamate-cystine anti-
porter and a drop in glutathione levels that allows for
aberrant formation of reactive oxygen species (ROS) that
are neurotoxic [77-79]. In most of our studies, we and a
number of other investigators have used higher concentra-
tion (mM) and exposed the cultures to longer exposure
times (hours vs minutes) to glutamate. Under these con-
ditions, we usually get 30 to 50% cell death. This cell
death occurs most likely by mechanism distinct from exci-
totoxicity induced by acute exposure of neurons to μM
concentrations of glutamate. We think as indicated in the
first sentence in the background it is the high concentra-
tions (mM) of the excitatory neurotransmitter glutamate
that accumulates in the aging brain that may play a role in
neurodegeneration associated with normal aging. In con-
trast, in acute trauma to the brain, excitotoxicity may be
the key factor. In our recent study [13] in primary cultures
of cortical neurons, we investigated the glutamate-
induced excitotoxicity by exposing the neurons to μM
concentration of glutamate for only 20 minutes. The
results from this study indicated that glutamate-induced
cell death occurs through NMDA receptors and NOS-
linked mechanism independent of Ca2+ influx and this
form of cell death was also prevented by estrogens. Thus,
depending on the objectives of the study, we have used
different concentrations of glutamate. Important to note
that in HT22 cells, NMDA receptors are absent and there-
fore this form of excitotoxicity may not occur in these
types of neuronal cells.
Since in our study both NMDA receptor and estrogen
receptor positive (primary cortical cells) and negative
(HT22) cells were used, the results therefore indicate that
at least two different mechanisms are involved in the acti-BMC Neuroscience 2006, 7:49 http://www.biomedcentral.com/1471-2202/7/49
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vation of calpains. Which of these mechanisms is
involved in neurodegenerative diseases such as Alzhe-
imer's remains to be investigated. It is likely that in the
aging brain, neurons are more sensitive to chronically
high levels (mM) of glutamate that can result in the acti-
vation of calpains and the initiation of neurodegenerative
process. Over time, the caspase-3 system is also activated
leading to a higher degree of apoptotic neuronal cell death
and progression of the disease process. The demonstra-
tion that equine estrogens can prevent the activation of
both types of proteases, provides an avenue of developing
new therapeutic interventions for the prevention of neu-
rodegenerative diseases.
Conclusion
Our present studies demonstrate that at least two mecha-
nisms are involved in glutamate-induced apoptosis: a cas-
pase-dependent pathway via a caspase-3 cascade and a
caspase-independent pathway involving calpain protease
and AIF-mediated apoptosis. Since HT22 cells lack cas-
pase-3 protein and activity, glutamate-induced apoptosis
is mediated via the caspase-independent pathway in this
particular cell line. Our data also suggest that calpain,
rather than caspase-3, plays a critical role in the neuronal
intracellular pathway leading to glutamate-induced apop-
tosis. Our studies further indicate that glutamate-induced
changes in these apoptotic proteins can be inhibited by
estrogens, with Δ8,17β-estradiol, a novel equine estrogen
being more potent than 17β-estradiol. To our knowledge,
this is the first demonstration that glutamate-induced
apoptosis involves regulation of multiple apoptotic effec-
tors that can be inhibited by estrogens. These data provide
an insight into the development of potential novel thera-
peutic approaches for the prevention of neurodegenera-
tive disease with estrogens and calpain inhibitors.
Methods
Materials
All primary and secondary antibodies along with other
reagents were purchased from commercial sources: pri-
mary antibodies, goat polyclonal antibody to AIF (sc
9416) and goat polyclonal antibody to Actin (sc1616)
from Santa Cruz Biotechnology, Inc (Santa Cruz, Ca).
Mouse monoclonal antibody to α-fodrin (FG 6090) (α II-
spectrin, non-erythroid) from Affiniti Research Products
(Hornby, ON). Estrogen receptor (ERα and ERβ) antibod-
ies were generously donated by Drs Istvan Merchenthaler
(Wyeth Inc) and Geoffrey Greene (University of Chicago).
Secondary antibodies against mouse and goat were pur-
chased from Sigma (Saint Louis, MI). SuperSignal® West
Pico Chemiluminescent Substrate was purchased from
PIERCE (Rockford, IL). Caspase inhibitors, Z-Val-Ala-DL-
Asp (OMe)-fluoromethylketone (Z-VAD-fmk) and Z-Asp
(OMe)-Glu (OMe)-Val-DL-Asp (OMe)- fluoromethylke-
tone (Z-DEVD-fmk) were purchased from Bachem Bio-
science Inc (King of Prussia, PA), and calpain inhibitors,
ALLN (Cat# 208719) and PD150606 (Cat# 513022) were
purchased from Calbiochem (Missisauga, ON) the Cyto-
tox 96 Non-radioactive Cytotoxicity Assay Kit (Promega
G1780) was obtained from VWR (Toronto, ON). Neuro-
basal, B27, Hanks' buffered salt solution (HBSS) and anti-
biotics were from Gibco Life technologies (Burlington,
ON). Other chemicals were of reagent grade and were
obtained from VWR, Canada.
Cell culture
The method used has been previously described in detail
[6,37]. Briefly, eighteen-day-old pregnant Sprague-Daw-
ley rats were sacrificed by cervical dislocation. Fetuses
were delivered and fetal skulls were carefully opened and
the meninges were removed. Two pieces of cortex (0.5–
1.5 × 1–2 mm) were cut from the posterior dorsal surface
from each of the fetuses and dispersed by mechanical dis-
sociation in Hank's balanced salt solution (HBSS, Ca2+
and Mg2+ free). Cells thus obtained, were suspended in 2
× volume of HBSS with Ca2+ and Mg2+ and allowed to set-
tle for 3 to 5 minutes. The supernatant was centrifuged at
1100 rpm (200 g) for 1 minute. The pellet was suspended
in HBSS buffer and fresh cell suspensions were plated
onto poly-L-lysine-coated 96-well plates (5 × 104/well) or
6-well plates (1 × 106/well) containing neurobasal
medium supplemented with 2% B27, 0.5 mM L-
glutamine, 25 μM glutamic acid, 120 mg/L penicillin and
260 mg/L streptomycin (NBC). The cells were then main-
tained at 37 C in a humidified incubator with 5% CO2/
95% air in NBC. After day 1 of plating, the media was
completely replaced and on subsequent days, 50% of the
media was replaced. Experiments were performed on 8
day cultures in neurobasal medium containing 2% anti-
oxidant free B27 supplement. Under these serum-free cul-
ture conditions, cells used are essentially pure (>95%)
neuronal as demonstrated previously [37]. We confirmed
the purity of our cultures by demonstrating the presence
of neuron specific enolase (NSE) and the absence of glial
fibrillary acid protein (GFAP). Almost all cells present in
the primary cortical cultures stained positively for only
NSE. These data clearly demonstrate the purity of our cul-
tures. The details of the methods used have been
described in our previous study [13]. The mouse hippoc-
ampal cell line (HT22) was grown as described previously
[5]. HT22 cells were plated in 96-well plates (3 × 104/well)
or 6-well plates (3 × 105/well) in Dulbecco's Modified
Eagle Medium (DMEM) containing 4.5 g/L glucose, 5 g/L
sodium bicarbonate, 10 mM Hepes, 120 mg/L penicillin,
75 mg/L streptomycin, 5% horse serum and 10% fetal
bovine serum. The cells were incubated at 37 C in a
humidified incubator with 5% CO2/95% air. After 24
hours, the medium was changed and cells were treated
with glutamate in the presence or absence of various con-
centrations of caspase and calpain inhibitors or estrogens.BMC Neuroscience 2006, 7:49 http://www.biomedcentral.com/1471-2202/7/49
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Determination of glutamate-induced cell cytotoxicity
Cell death was estimated using a validated LDH (Lactate
dehydrogenase) release assay as described previously
[5,6]. The release of lactate dehydrogenase in the culture
medium indicated loss of membrane integrity and cell
death. LDH activity in the culture medium was deter-
mined using the non-radioactive cytotoxicity assay kit
according to the manufacturer's protocol. The absorbance
at 490 nm was measured in a microplate reader (Spectra
MAX 340). In all experiments, cultures were also treated
with 0.1% Triton X-100 to lyse; the cells and LDH levels
measured under these conditions were taken as the maxi-
mal LDH release (100% cell death). The results are
expressed as a percentage of maximum LDH release. We
have previously established a strong correlation between
the MTS (3 [4,5-dimethylthiazol-2yl]-5 [3-carboxymeth-
oxyphenyl]-2H tetrazolium inner salt), cell proliferation
(viability) assay and the LDH assay [80]. In the MTS assay,
live cells once treated with the reagent are not further use-
able for other measurements. Since we wanted to use the
same cells for Western blot analysis, the LDH assay was
selected as in this assay, only the supernatant is used and
the cells can be processed for other determinations.
Western blot analysis
Protein levels of α-fodrin and apoptosis inducing factor
(AIF) were determined by Western blot analysis using pol-
yclonal and monoclonal antibodies raised against AIF and
α-fodrin respectively, as described previously [5,6]. In
brief, cells were washed twice with cold PBS, harvested
using a cell scraper, and lysed in a cell lysis buffer (9 mM
Na2PO4, 1.7 mM NaHPO4 and 150 mM NaCl, pH7.4),
containing 1% Nonidet P-40 (Sigma, Toronto, Canada),
0.5% sodium deoxycholate, 0.1% SDS and 1 mM phenyl-
methylsulfonylfluoride for 20 minutes on ice. Cell lysates
were centrifuged at 10,000 g at 4 C for 10 minutes. The
protein concentration was determined by Bradford
method (BioRad, Toronto, Canada). Cell lysates contain-
ing 10 to 20 μg protein were added to equal volume of 2
× reducing sample buffer (100 mM Tris-Cl pH 6.8, 200
mM dithiothretiol, 4% SDS, 20% glycerol, and 0.2%
Bromophenol blue) and heated at 100 C for 3 minutes.
The samples were separated by discontinuous 7% and
10% polyacrylamide gel electrophoresis under constant
current (14–15 mA). Separated proteins were electrotrans-
fered onto a Protan nitrocellulose membrane (Schleicher
& Schuell Inc., Keene N.H). The blots were blocked with
5% non-fat milk in TBST (20 mM Tris-HCl pH 7.6, 137
mM NaCl, 0.05% Tween-20) at 4 C overnight and then
incubated with primary antibody for 1–2 hours at room
temperature, washed three times with TBST and incubated
(1–2 hours) with appropriate horse radish peroxidase-
conjugated secondary antibody. The membranes were
washed three times with TBST and the immunoblots were
visualized on X-ray films (Sigma) after exposure to
enhanced chemiluminescence reagent (ECL), (Amer-
sham, Toronto, Canada). Actin bands were monitored on
the same blot to verify consistency of protein loading.
Briefly, the immunoblots were stripped with TBST con-
taining 0.04% sodium azide for 30 minutes at room tem-
perature. The blots were probed with anti-actin primary
antibody and secondary antibody (anti-goat) as described
above. The molecular size of protein was determined by
running pre-stained protein markers in an adjacent lane,
omitting primary antibody as a procedural control. Each
experiment was repeated at least three times. The band
intensity was measured from scanned images using UN-
SCAN IT Gel Automated Digitizing system, Version 5.1
(Silk Scientific, Inc. Orem, Utah, USA), software.
RT-PCR assay
Total RNA were extracted from cortical cells by using RNe-
asy Mini Kit (Qiagen Inc, Mississauga, ON) according to
the manufacturer's protocol. The concentration of total
RNA was determined by reading the absorbance at 260
nm in a spectrophotometer. Semi-quantitative RT-PCR
was performed to assess the expression of estrogen recep-
tor mRNA (ERα and ERβ) with G3PDH as an internal con-
trol. Briefly, cDNA synthesis (RT) was performed with 1–
1.5 μg total RNA in 30 μl RT mixture buffer containing 50
mM Tris-Cl, pH 8.5, 75 mM KCl, 3 mM MgCl, 10 mM
DTT, 1 mM dNTP, 250 ng random primer, 3.5 units
RNase inhibitor (Pharmacia), 200 units AMV reverse tran-
scriptase (Superscript II, GIBCO BRL). The mixture was
incubated first at 25 C for 10 min and then 42 C for 60
min and the reaction was terminated by heating at 95 C
for 5 min. PCR amplifications were carried out using 5 μl
aliquot of each RT products (cDNA templates) in 50 μl
PCR reaction mixture, containing 0.2 mM dNTP, 10 mM
Tris-Cl, 10 mM KCl (pH 8.3), 2.5 mM MgCl2, 2.5 units of
Tag DNA polymerase Stoffel fragment (ApliTag, Perkin
Elmer) and 50 pmol of each primer for 30 cycles. Each
PCR cycle consisted of 94 C for 40 sec, 60 C for 40 sec s
and 72 C for 40 sec, following an initial denaturation at
94 C for 3 min. Specific primers based on the cDNA
sequences of rat ERα and ERβ were: ERα (287 bp): sense
5'-TCC TCC TAG ACC CTT CAG TGA AGC C-3'; antisense
5'-ACA TGT CAA AGA TCT CCA CCA TGC C-3'; ERβ (203
bp): sense 5'-AAA GCC AAG AGA AAC GGT GGG CAT-3';
antisense 5'-GCC AAT CAT GTG CAC CAG TTC CTT-3'
and G3PDH, sense 5'-GCC ATC AAT GAC CCC TTC ATT
GAC C-3'; antisense 5'-CAT CAC GCC ACA GTT TCC CGG
AG-3'). The PCR products were analyzed in TBE 1.5% aga-
rose gel and confirmed by DNA sequencing. The PCR
primers used have been previously described [38,39].
Assessment of the effects of caspase and calpain inhibitors
Cultures were treated with glutamate in the presence or
absence of various amounts of calpain specific inhibitor
PD150606 (selective calpain antagonist to block the cal-BMC Neuroscience 2006, 7:49 http://www.biomedcentral.com/1471-2202/7/49
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cium binding site of calpain, 1–100 μM) [40]; ALLN (cal-
pain I inhibitor, 1–50 μM), the specific caspase-3
inhibitor (z-DEVD-fmk, 1–100 μM) and a pancaspase
inhibitor (z-VAD-fmk, 1–100 μM). All protease inhibitors
were prepared as 20 mM stocks in DMSO and stored at -
80 C until needed.
Determination of DNA fragmentation by gel 
electrophoresis
Apoptotic cells produce characteristic DNA ladders and
their formation was assayed as previously described [6].
Briefly, cultured cells were washed with ice cold TBS (20
mM Tris-HCI, pH 7.6, 137 mM NaCI), DNA was isolated
and 5 μg of DNA was electrophoresed on a 1.5% agarose
gel for 1.5 hour at 200 V. The DNA fragments were visual-
ized by UV transillumination after being staining with
ethidium bromide.
Measurement of AIF translocation
The cells were washed twice with ice-cold PBS, pH 7.4 and
then suspended in cold isotonic buffer (250 mM sucrose,
20 mM Hepes-KOH, 10 mM KCl, 1.5 mM MgCl2, 1 mM
Na-EDTA, 1 m M Na-EGTA, 1 mM dithiothretiol and pro-
tease inhibitors). After a 15 minute incubation on ice,
cells were homogenized using a glass homogenizer on ice
(25 strokes). Cell homogenates were spun at 750 g for 10
min and the pellet containing nuclei was stored at -80 C
until analyzed. The supernatant was further centrifuged at
10,000 g for 15 minutes. The pellets containing mito-
chondria were stored at -80 C until processed. The super-
natant was further centrifuged at 100,000 g for 1 hour at
4 C to obtain the cytosolic fraction (S-100). The intactness
of the mitochondrial membranes was checked by assaying
the mitochondrial specific enzyme glutamate dehydroge-
nase (GDH) in mitochondria, mitochondria treated with
Triton X-100 and the cytosol (S-100) as described previ-
ously [6,15]. GDH was only detectable in mitochondria
and mitochondria treated with Triton X-100, but was
undetectable in the cytosol. Thus, the cytosolic fraction
was free of mitochondrial contamination. Following anal-
ysis of protein concentration, the levels of AIF in those
fractions were analyzed by Western blots using goat or
rabbit anti-AIF antibody according as described above.
Statistics
Each experiment was repeated at least three times and the
combined data were evaluated by analysis of variance
(ANOVA). Values are given as mean ± SE. Differences were
considered significant at p < 0.05.
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